Longboard Pharmaceuticals Inc. Stock Price, News, Quote & History

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.

Longboard Pharmaceuticals Inc.

Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates

5 US Longevity and Anti-aging Stocks to Watch in 2025

Top 5 Small-cap Biotech Stocks of 2025

Latest News

80 Mile PLC Secures 3 Strategic MOUs with Fortune 500 Energy Group, Ludoil, and JEnergy and moves to 100% of Ferrandina Biofuels Plant

Appointment of Financial Adviser and Sponsor

Cotec Purchases Commercial Scale Salter Cyclone Multi-Gravity-Separator Unit to be Located at Corem Québec, Canada

TSX-V: TT Closes Acquisition of High Lake and West Hawk Lake from McFarlane Lake Mining and Closing of Final Tranche of Non-Brokered Private Placement

Element One Hydrogen and Critical Minerals Announces Letter of Intent to Acquire Hydrogen and Critical Mineral Extraction Technology

Latest News

Outlook Reports world

Featured Biotech Investing Stocks

Browse Companies